ESTE charts & data provided by TradingView

Latest Insights on ESTE

We asked you for DoorDash opinions, and boy, we got ‘em! Get the latest on the DoorDash IPO — and if should buy in when DASH goes public. DoorDash Rehash; I’m With the BAND; Uber’s Robo-Taxi No More November 19, 2020 by Joseph Hargett Great Stuff Knocking on Heaven’s Door(Dash) Great Ones … welcome to Reader Feedback day! If you happen to be new ‘round these parts, today’s the day that Great Stuff answers your questions, researches your investment ideas and indulges in your rants … whatever the topic may be. Seriously. Last week, we covered everything from artificial intelligence to […]
Whether you believe it’s God’s gift to money or a mania waiting to unwind, you have to admit that bitcoin can go higher. Can You Afford Not to Own Some Bitcoin? November 19, 2020 by Brian Christopher Cryptocurrency, Winning Investor Daily Whether you believe it’s God’s gift to money or a mania waiting to unwind, you have to admit that bitcoin can go higher.
As the crypto bull market unfolds, it looks like altcoins are positioned to climb dramatically again. Forget Bitcoin: Buy Altcoins for Bigger Gains November 17, 2020 by Steve Fernandez Cryptocurrency, Winning Investor Daily As the crypto bull market unfolds, it looks like altcoins are positioned to climb dramatically again.
Can you be too cool for the vaccine race? As it turns out, yes you can! With Moderna’s vaccine coming in hot, Pfizer just got one-upped. Pfizer Pforfeit; A Nio Dealio; Uber’s Hail Mary November 16, 2020 by Joseph Hargett Great Stuff Born to Run In the day, we sweat it out on Wall Street. It’s a runaway American dream. At night, we’re locked in mansions of glory, no more suicide machines. But all that might be about to change… Sprung from Phase 3 on highway nine, Moderna’s new injection is stepping out over the line. (Woah!) […]
The effectiveness of the COVID-19 vaccine is remarkable. But what’s even more remarkable is that a relatively small firm played such a large role in developing it. COVID-19 Vaccine Firm Soars 650% — Huge Opportunities Ahead November 14, 2020 by Jay Goldberg Investment Opportunities, Winning Investor Daily The effectiveness of the COVID-19 vaccine is remarkable. But what’s even more remarkable is that a relatively small firm played such a large role in developing it.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”

- David G. (Member since 2018)

Share This